Health-care industry deals continue to increase in 2021, with health IT and life science and pharmaceuticals the top two sectors, according to Epstein Becker Green attorneys and health industry financial/investment analysts at KPMG and FocalPoint Partners, Bloomberg reports.
They predict a possible record year, with many deals set to close by the end of the year in light of uncertainty around tax rate changes, as well as other factors, including high valuations in the current market. Read more.
